Cancer developer Merrimack dives into a tough IPO pool with a $172M filing
13 July 2011
Nancy Faigen
Please Login to read the full article.
13 July 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Pain drug developer Horizon Pharma takes a shot at $49.5M IPO, below expected range
- Cempra dives into tough IPO pool, filing $86M IPO for Phase II antibiotics
- Ambit raises $30M more VC after pulling IPO, but expects to go public after pivotal trial
- Third time's the charm for $100 million Merrimack IPO after two false starts
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
